616 Krankheiten
Refine
Has Fulltext
- yes (173) (remove)
Is part of the Bibliography
- yes (173)
Year of publication
Document Type
- Journal article (173) (remove)
Language
- English (173)
Keywords
- breast cancer (6)
- Fabry disease (5)
- Parkinson’s disease (4)
- dopamine (4)
- follow-up (4)
- oxidative stress (4)
- quality of life (4)
- schizophrenia (4)
- MRI (3)
- Mice (3)
- antibodies (3)
- brain (3)
- chronic kidney disease (3)
- enzyme replacement therapy (3)
- gene (3)
- genetics (3)
- heart failure (3)
- hypertrophic cardiomyopathy (3)
- magnetic resonance imaging (3)
- mice (3)
- mortality (3)
- mouse model (3)
- prognosis (3)
- survival (3)
- ADHD (2)
- AIDS (2)
- B cells (2)
- CSF (2)
- Fabry (2)
- Fabry nephropathy (2)
- Fabry-associated pain (2)
- HIV (2)
- IL-10 (2)
- Inflammation (2)
- P300 (2)
- Pain (2)
- Parkinson disease (2)
- Parkinson's disease (2)
- Therapy (2)
- anxiety (2)
- back pain (2)
- basal ganglia (2)
- biomarker (2)
- biomarkers (2)
- cancer treatment (2)
- cardiovascular disease (2)
- cardiovascular events (2)
- cell cultures (2)
- children (2)
- coronary heart disease (2)
- deep brain stimulation (2)
- depression (2)
- disease (2)
- epidemiology (2)
- expression (2)
- family (2)
- fibrosis (2)
- fracture (2)
- gastric cancer (2)
- gene expression (2)
- genome-wide association (2)
- hearing loss (2)
- hemodialysis (2)
- hip (2)
- hospitalization (2)
- human immunodeficiency virus (2)
- impact (2)
- infection (2)
- inflammation (2)
- leukemia (2)
- lung (2)
- lung cancer (2)
- magnetic resonance (2)
- major depressive disorder (2)
- melanoma (2)
- messenger RNA (2)
- metaanalysis (2)
- multiple sclerosis (2)
- mutation (2)
- myasthenia gravis (2)
- myocardial infarction (2)
- oncolytic viruses (2)
- osteoarthritis (2)
- osteoporosis (2)
- population (2)
- predictors (2)
- prevalence (2)
- prostate cancer (2)
- protein (2)
- pulmonary embolism (2)
- randomized controlled trial (2)
- risk (2)
- risk factors (2)
- sepsis (2)
- shock (2)
- stroke (2)
- surgery (2)
- susceptibility (2)
- teriparatide (2)
- therapy (2)
- treatment (2)
- trial (2)
- update (2)
- validation (2)
- validity (2)
- ventilation (2)
- walking (2)
- 1p13.3 (1)
- 1q21 (1)
- 1st International Workshop (1)
- 2B (1)
- 5-Fluorouracil (1)
- 5IA-SPECT (1)
- 7q11.2 (1)
- A53T (1)
- ADAMTS (1)
- ALS (1)
- Acute Myocardial Infarction (1)
- Adrenocortical Carcinoma (1)
- Agalsidase beta therapy (1)
- Akutes Nierenversagen (1)
- Alpha galactosidase (1)
- Alzheimer's disease (1)
- Alzheimer’s disease (1)
- Amino acids (1)
- Anderson-Fabry Disease (1)
- Ankyrin (1)
- ApoE\(^{(-/-)}\) (1)
- Arterial water (1)
- Attention-deficit/hyperactivity disorder (1)
- B lymphocytes (1)
- B-cell lymphoma (1)
- BCI (1)
- BK virus (1)
- BRAF mutation (1)
- BRCA1 (1)
- Barrett-Ösophagus (1)
- Barthel-Index (1)
- Bessle functions (1)
- Beta-glucocerebrosidase (1)
- Biomarkers (1)
- Blood-brain barrier (1)
- Brain (1)
- Breast cancer (1)
- Breast-tumors (1)
- C-MYC (1)
- CBF (1)
- CD4 T cells (1)
- CMV (1)
- CNO (1)
- CRMO (1)
- Capicua transcriptional repressor (1)
- Cardiovascular Magnetic Resonance (1)
- Charcot–Marie–Tooth disease (1)
- Chemotherapy (1)
- Childhood (1)
- Clinical manifestations (1)
- Coefficient (1)
- Comorbidities (1)
- Comorbidity survey replication (1)
- D313Y genotype (1)
- DAT (1)
- DIRA (1)
- DNA (1)
- DNA Methylation (1)
- DRD2 (1)
- DSM-5 (1)
- DSM-IV (1)
- DSM-IV disorders (1)
- Deflazacort (1)
- Demyelinating peripheral neuropathy (1)
- Depression (1)
- Diagnosis (1)
- Disease (1)
- Disease progression (1)
- Disease-modifying therapies (1)
- Draize eye test (1)
- Drug development (1)
- Drug resistance (1)
- Duchenne dystrphy (1)
- E3 ubiquitin ligase (1)
- EAU guidelines (1)
- EBV (1)
- EDS (1)
- ELISPOT (1)
- ENV (1)
- EORTC-BN20 (1)
- EORTC-QLQ-C15-PAL (1)
- EQ-5D (1)
- EUROASPIRE survey (1)
- Early-onset (1)
- Ehlers-Danlos syndrome (1)
- Enzyme replacement therapy (1)
- Enzyme-Linked Immunospot assay (ELISPOT) (1)
- Epilepsy (1)
- Epstein-Barr-virus (1)
- Experimental stroke (1)
- Extramedullary disease (1)
- F-19 MRI (1)
- FDG (1)
- FDG-PET/CT (1)
- FDG-PET/MRI (1)
- FP-CIT SPECT (1)
- Fabry cardiomyopathy (1)
- Fabry patient (1)
- Follow-up (1)
- Fontan’s Operation (1)
- Frabin/Fgd4 (1)
- GLA protein UCMGP (1)
- GP41 cytoplasmic tail (1)
- Gene-expression (1)
- HAND (1)
- HCMV infection (1)
- HE-3 diffusion MRI (1)
- HER2 (1)
- Haemodialysis (1)
- Heart failure (1)
- Heart failure with preserved ejection fraction (1)
- Heart failure with reduced ejection fraction (1)
- Helicobacter pylori (1)
- Hepatitis C infection (1)
- Hodgkin-lymphoma (1)
- Homoarginine (1)
- Hurst Exponent (1)
- ICD-coding of CKD (1)
- IFN-γ (1)
- IL-2 (1)
- IL28B (1)
- IMpACT (1)
- Illumina Human Exome Bead Chip (1)
- Images (1)
- In-vivo (1)
- Infarct Zone (1)
- Insulin Degrading Enzyme (1)
- Iron Oxide Nanoparticle (1)
- Iron-oxide (1)
- Iron-uptake (1)
- Krebs (1)
- L-arginine (1)
- LC-ESI/MS/MS (1)
- LIMP-2 (1)
- LPHN3 (1)
- LV mass (1)
- Lesions (1)
- Lewy-like pathology (1)
- Limb girdle muscular dystrophy (LGMD) (1)
- Lipom (1)
- Lyso-Gb3 (1)
- MCPH1 (1)
- MRI reporter (1)
- MS (1)
- MTCH2 (1)
- Magnetic-resonance (1)
- Majeed (1)
- Metaanalysis (1)
- MicroRNAs (1)
- Miyoshi myopathy (1)
- Morbus Fabry (1)
- Multiple myeloma (1)
- Multiple sclerosis (1)
- Mycobacterium caprae (1)
- Mycobacterium tuberculosis complex (1)
- N-Myc down regulated gene 1 (1)
- NADPH oxidase inhibitors (1)
- NADPH oxidases (NOX) (1)
- NCAM1 (1)
- NMO-IGG (1)
- NPU (1)
- NRG1 (1)
- Neuropathy (1)
- Neuroprotection (1)
- Normal breast (1)
- OECD guideline (1)
- OncotypeDX\(^{®}\) (1)
- Outcome survey (1)
- Ovarian (1)
- P. falciparum (1)
- PAI-1 (1)
- PAPA (1)
- PDH (1)
- PET/CT (1)
- PSMA (1)
- Parkinson (1)
- Parkinsons disease (1)
- Particles (1)
- Perfusion (1)
- Pharmacological management (1)
- Physical impairment (1)
- Prevalence (1)
- Primary cell lines (1)
- Prostatakrebs (1)
- Proteins (1)
- Pycnogenol (1)
- Quality of life (1)
- RDoC (1)
- RNA interference (1)
- Randomized controlled trial (1)
- Rats (1)
- Rho-GTPase Cdc42 (1)
- Rochester diabetic neuropathy (1)
- SAH (1)
- SCD (1)
- SCF (1)
- SKP1 (1)
- SVR (1)
- Salmonella-typhimurium (1)
- Scale (1)
- Short dsRNA oligonucleotides (1)
- Small-fiber neuropathy (1)
- Soft-tissue infection (1)
- Stem cells plasticity (1)
- Strahlentherapie (1)
- Sudden cardiac death (1)
- Sugar-transport (1)
- Superparamagnetic Iron Oxide (1)
- Surrogate endpoints (1)
- T-DM1 (1)
- T-PA (1)
- T-cell reactivity (1)
- TIC disorders (1)
- TLR4 (1)
- TNF-α (1)
- Thyroid cancer (1)
- Tissue engineering (1)
- Tracking (1)
- Treatment (1)
- Trypanosoma (1)
- Tuberkulose (1)
- UME6 (1)
- United States (1)
- V. saphena magna (1)
- VAL66MET polymorphism (1)
- Virologie (1)
- Von-Willebrand-factor (1)
- WB-DW-MRI (1)
- ablation (1)
- accuracy (1)
- acetylsalicylic acid exacerbated respiratory disease (1)
- acoustic startle (1)
- acquired immunodeficiency-syndrome (1)
- activation (1)
- acute (1)
- acute ischemic stroke (1)
- acute kidney injury (1)
- acute liver failure (1)
- acute management of stroke (1)
- acute neurology (1)
- acute stroke imaging (1)
- acute stroke management (1)
- acute stroke outcome (1)
- adalimumab (1)
- adjuvant (1)
- adrenal cortex hormones (1)
- adrenal cortex neoplasms (1)
- adrenal imaging (1)
- adrenal tumours (1)
- adult (1)
- adulthood (1)
- aerobic glycolysis (1)
- agalsidase-beta (1)
- age (1)
- alendronate (1)
- alkaline phosphatase (1)
- allergic rhinitis (1)
- allografts (1)
- alpha galactosidase (1)
- alpha-galactosidase A (1)
- alpha-galactosidase-A (1)
- alpha-synuclein (1)
- alternatives (1)
- alveolar (1)
- amyotrophic lateral sclerosis (1)
- animal model (1)
- animal models (1)
- anti-aquaporin-4 antibody (1)
- antigen (1)
- antioxidant function (1)
- antirheumatic agents (1)
- aortic valve (1)
- aortic valve disease (1)
- apomorphine (1)
- apoptosis (1)
- aquaporin-4 autoantibodies (1)
- argeted therapy (1)
- arm (1)
- artery occlusion (1)
- arthritis (1)
- arthroplasty (1)
- aspirin sensitivity (1)
- aspirin-induced asthma (1)
- association (1)
- asthma (1)
- astrocytic tumor (1)
- atypical (1)
- auditory (1)
- autism (1)
- autoimmunity (1)
- autonomous cortisol secretion (1)
- awareness (1)
- axonopathic changes (1)
- axons (1)
- beta oscillations (1)
- beta-TRCP (1)
- binding (1)
- binge eating (1)
- bioinformatics (1)
- biopsy findings (1)
- biosynthesis (1)
- bipolar disorder (1)
- blood biomarker (1)
- blood brain barrier (1)
- blood-glucose control (1)
- bone (1)
- bone colonization (1)
- bone formation (1)
- bone marrow transplantation (1)
- bone-mineral density (1)
- brain cancer (1)
- brain computer interface (1)
- brain edema (1)
- brain tumours (1)
- calcium (1)
- cancer (1)
- cancer patients (1)
- carcinomas (1)
- cardiac energy metabolism (1)
- cardiac hypertrophy (1)
- cardiac magnetic resonance imaging (1)
- cardiogenic (1)
- cardiopulmonary exercise testing (1)
- cardiovascular care (1)
- cardiovascular magnetic-resonance (1)
- cardiovascular morbidity (1)
- cardiovascular risk factors (1)
- cartilage (1)
- cell cycle (1)
- cell-cycle arrest (1)
- cells (1)
- cellular proteins (1)
- central nervous system (1)
- cerebrospina (1)
- cerebrospinal fluid culture (1)
- cerebrospinal-fluid (1)
- chemical properties (1)
- chemotherapy (1)
- childhood cancer (1)
- chip analyses (1)
- chronic distress (1)
- chronic heart failure (1)
- chronic kidney-disease (1)
- chronic thromboembolic pulmonary hypertension (1)
- chronic viral infection (1)
- classification (1)
- clinical (1)
- clinical diagnosis (1)
- clinical study (1)
- clinical trials (1)
- clinical-practice (1)
- coefficient (1)
- cognitive decline (1)
- collarless (1)
- colony-stimulating factor (1)
- colorectal cancer (1)
- common SNPS (1)
- complex diseases (1)
- complex disorders (1)
- complication (1)
- comprehensive management (1)
- comprehensive psychosomatic assessment (1)
- computed tomography (1)
- consortium (1)
- contrast-enhanced MRI (1)
- controlled clinical-trials (1)
- coordination (1)
- copy number variants (1)
- cornea verticillata (1)
- corneal equivalent (1)
- coronary artery disease (1)
- coronary calcification (1)
- coronary-artery calcification (1)
- coverage (1)
- crantiectomy (1)
- craving (1)
- creatine synthesis (1)
- critically ill (1)
- cryptogenic stroke (1)
- cue (1)
- cystic fibrosis (1)
- cytokine (1)
- cytokine secretion kinetics (1)
- cytomegalovirus (1)
- damage responses (1)
- darbepoetin alpha (1)
- database (1)
- decompressive surgery (1)
- degeneration (1)
- dehydrogenases (1)
- dendritic cells (1)
- dentate gyrus (1)
- dependency (1)
- design (1)
- dexamethasone suppression test (1)
- diabetes complications (1)
- diabetes mellitus (1)
- diabetes mellitus type 2 (1)
- diabetic mouse (1)
- diabetic nephropathy (1)
- diagnosis (1)
- dialysis (1)
- differentially expressed genes (1)
- differentiation (1)
- diffusion weighted MRI (1)
- diffusion-weighted MRI (1)
- disease progression (1)
- disease-modifying therapies (1)
- disorder (1)
- dolutegravir (1)
- dopamine acetylcholine (1)
- double-blind (1)
- drug development (1)
- duchenne muscular dystrophy (1)
- duodenal levodopa infusion (1)
- dysferlinopathy (1)
- dyspnea (1)
- early diagnosis (1)
- ejection fraction (1)
- electroporation (1)
- elispot (1)
- elucidation (1)
- embolic stroke (1)
- emotional regulation (1)
- emtricitabine (1)
- encephalitis dementia (1)
- end stage renal disease (1)
- endocrinology (1)
- endogenous psychoses (1)
- endophenotype (1)
- endotheliopathy (1)
- endotoxemia (1)
- entorhinal cortex (1)
- environment (1)
- enzyme-linked immunoassays (1)
- epigastric hernia (1)
- epimutation (1)
- eukaryota (1)
- euroaspire (1)
- exacebrated respiratory-disease (1)
- exhaustion (1)
- experimental (1)
- experimental autoimmune encephalomyelitis (1)
- expression pattern (1)
- extensiv transverse myelitis (1)
- extracellular matrix (1)
- extracellular matrix remodeling (1)
- extracorporeal membrane oxygenation (1)
- eye irritation testing (1)
- fMRI (1)
- factor expression (1)
- fatty liver disease (1)
- fear of progression (1)
- feasibility (1)
- femoral revision (1)
- fetuin A (1)
- fibrosis progression (1)
- field (1)
- fluid (1)
- fluorescent-probes (1)
- focal cerebral ischemia (1)
- focal semental glomerulosclerosis (1)
- folinic acid (1)
- food addiction (1)
- fosfomycin (1)
- foxes vulpes-vulpes (1)
- frontal cortex (1)
- functional imaging (1)
- functional neuroanatomy (1)
- gadofluorine (1)
- gadolinium-DTPA (1)
- gait (1)
- gait analysis (1)
- gambling (1)
- gastroesophageal reflux (1)
- gastroesophageal reflux disease (1)
- gemcitabine (1)
- gene ontology (1)
- gene-environment interaction (1)
- genetic heterogeneity (1)
- genetic interaction (1)
- genetic modifiers (1)
- genetic renal disease (1)
- genetic risk factor (1)
- genetic variation (1)
- genome-wide association study (GWAS) (1)
- genomic damage (1)
- germinal center (1)
- giant ventral hernia (1)
- gilles (1)
- glioblastoma cell-lines (1)
- glioblastoma multiforme (1)
- glomerular-filtration-rate (1)
- glucose transporter (1)
- glycoprotein incorporation (1)
- granzyme B (1)
- green fluorescent protein (1)
- gridle muscular-dystrophy (1)
- group-B (1)
- growth (1)
- growth factor (1)
- guideline adherence (1)
- guideline implementation (1)
- guidelines (1)
- haplogroups (1)
- hcv infection (1)
- health care research (1)
- health questionnaire (1)
- health-related quality of life (1)
- heat shock protein Hsc-70 (1)
- helminths (1)
- hematopoietic (1)
- hematopoietic stem cells (1)
- hemicraniectomy (1)
- heptacellular carcinoma (1)
- hereditary motor and sensory neuropathy (1)
- heritability (1)
- herpes virus (1)
- hospital medical complications (1)
- host genetics (1)
- human (1)
- human cancer diseases (1)
- human cytomegalovirus (HCMV) (1)
- human diseases (1)
- humanized bone models (1)
- hyperpolarized HE-3 (1)
- hyponatremia (1)
- imaging mass spectrometry (1)
- immune neuromelanin (1)
- immune response (1)
- immune suppression (1)
- immune-response (1)
- immunity (1)
- immunoglobulin-G (1)
- immunohistochemistry (1)
- immunology and microbiology section (1)
- impaction bone grafting (1)
- impulse control disorders (1)
- in situ guided tissue regeneration (1)
- in vivo (1)
- incisional hernia (1)
- induced insulin-release (1)
- infants (1)
- infectious-disease diagnostics (1)
- infiltrate (1)
- inflammatory diseases (1)
- inguinal lymph node dissection (1)
- inherited metabolic disorders (1)
- inhibitor (1)
- initial experience (1)
- insulin (1)
- insulin receptor (1)
- insulin-like growth factor 1 receptor (1)
- integrase inhibitor (1)
- interval timing (1)
- intractable hiccup (1)
- invasive cysticerocsis (1)
- involvement (1)
- irinotecan (1)
- iron oxide nanoparticles (1)
- ischaemic stroke (1)
- ischemic stroke (1)
- journals (1)
- juvenile idiopathic arthritis (1)
- kidney (1)
- kidney neoplasms (1)
- kidney-disease CKD (1)
- kidneys (1)
- kinases (1)
- kinematics (1)
- kinetics (1)
- knees (1)
- laparostomy (1)
- late gadolinium enhancement (1)
- latency (1)
- left lateral wall (1)
- left ventricular mass (1)
- left-ventricular hypertrophy (1)
- lipid desaturation (1)
- lipidomics (1)
- lipoxygenase (1)
- liver resection (1)
- locally advanced disease (1)
- loci (1)
- locus coeruleus (1)
- lovastatin (1)
- lung and intrathoracic tumors (1)
- lymph nodes (1)
- lymphoma (1)
- lysosomal storage disease (1)
- mTOR-inhibitor RAD-001 (1)
- magnetic resonance spectroscopy (1)
- magnetic resonsance imaging (1)
- magnetic-resonance behavior (1)
- magnetic-resonance-spectroscopy (1)
- malaria (1)
- malignant MCA infarct (1)
- malignant lymphoma (1)
- malignant melanoma (1)
- management (1)
- maritime pine bark extract (1)
- mass spectrometry (1)
- matrix metalloproteinase (1)
- measles (1)
- mechanical energy (1)
- mechanisms (1)
- memory (1)
- memory cells (1)
- memory deficits (1)
- meningococcal disease (1)
- meningococcal polysaccharides (1)
- mesenchymal tissues (1)
- metabolism (1)
- metabolomics (1)
- metastasis (1)
- microRNAs (1)
- microRNA–target interaction (1)
- microangiopathy (1)
- microarray (1)
- microarrays (1)
- microcephalin 1 (1)
- microdeletion (1)
- migraineur (1)
- mineral metabolism (1)
- mineralocorticoid antagonist (1)
- missing heritability (1)
- mitochondria (1)
- modular (1)
- modulation (1)
- molecular genetics (1)
- molecular medicine (1)
- monozygotic twins (1)
- mood disorder (1)
- morbidity (1)
- morphogenesis (1)
- morphometry (1)
- motor function (1)
- mouse models (1)
- movements (1)
- multicenter (1)
- multigene-array (1)
- multimodal (1)
- multiple diseases (1)
- multiple myeloma (1)
- multiple system atrophy (1)
- multiple-sclerosis (1)
- murine gammaherpesvirus 68 (1)
- muscle strength (1)
- mutant p53 (1)
- myelin (1)
- myelination (1)
- myeloid (1)
- myocardial lipid content (1)
- nab-paclitaxel (1)
- national health survey (1)
- natural-history data (1)
- neoadjuvant (1)
- neoadjuvant chemotherapy (1)
- nerve fibers (1)
- nerve ultrasonography (1)
- nervous system (1)
- neural apoptosis (1)
- neural stem cells (1)
- neuregulin-1 (1)
- neuroinflammation (1)
- neuromelanin (1)
- neuron navigator 3 (1)
- neuroprotection (1)
- neuropsychiatric disorders (1)
- neurotrophic factor (1)
- neurotrophic factor gene (1)
- nicotinic receptors (1)
- nictric-oxide (1)
- noradrenalin (1)
- norepinephrine (1)
- nuclear antigen (1)
- nuclear magnetic resonance (1)
- nucleus (1)
- nucleus accumbens (1)
- number (1)
- obesity (1)
- observational study (1)
- oligonucleotides (1)
- open abdomen (1)
- optical coherence tomography (1)
- oral anticancer drugs (1)
- outcomes (1)
- overdose (1)
- oxaliplatin (1)
- p53-dependent apoptosis (1)
- p53-inducible regulator (1)
- pain (1)
- pain questionnaire (1)
- pancreatic cancer (1)
- parkinson disease (1)
- particles (1)
- partitioning analysis RPA (1)
- patient (1)
- patients’ awareness (1)
- pediatric (1)
- peptide vaccination (1)
- peripheral neuropathy (1)
- persistence (1)
- persistent ADHD (1)
- perspectives (1)
- pet (1)
- pharmacotherapy (1)
- phase contrast (1)
- phenotype (1)
- phosphodiesterase (1)
- physicians’ awareness (1)
- pine bark extract (1)
- plasma membrane (1)
- plasmid construction (1)
- plasmodium falciparum (1)
- platelet dysfunction (1)
- podocyte (1)
- point-of-care echocardiography (1)
- polymorphism (1)
- polymorphisms (1)
- polyomavirus (1)
- polyphenols (1)
- porous-coated stems (1)
- postoperativ (1)
- prednisone (1)
- preserved ejection fraction (1)
- prevalent fractures (1)
- prognostic index (1)
- progression (1)
- proliferation (1)
- prostatic neoplasms (1)
- prosthesis (1)
- proteasome (1)
- protein-protein interaction network (1)
- proteinuria (1)
- proteolipid protein gene (1)
- proton (1)
- psychiatric disorders (1)
- psychopathology (1)
- pulmonary artery (1)
- pulmonary artery pressure (1)
- pulmonary circulation (1)
- pulmonary hypertension (1)
- pulse wave velocity (1)
- pulses (1)
- qPCR (1)
- quality indicators (1)
- quality of health care (1)
- quality-of-care (1)
- radiation oncology (1)
- radical cystectomy (1)
- radiotherapy (1)
- randomized controlled study (1)
- rankin scale (1)
- rare diseases (1)
- rat (1)
- rat kidney (1)
- recurrence (1)
- recurrent Tako-Tsubo cardiomyopathy (1)
- reflex (1)
- regenerative medicine (1)
- regional recurrence (1)
- registries (1)
- registry (1)
- regression analysis (1)
- regulator (1)
- regulatory T cell (1)
- reliability (1)
- renal cancer (1)
- renal fibrosis (1)
- renal function (1)
- renal osteodystrophy (1)
- replacement (1)
- replacement therapy (1)
- respiratory virus (1)
- response evaluation (1)
- responsiveness (1)
- resting tremor (1)
- restoration (1)
- resveratrol (1)
- retinal ganglion cells (1)
- retinocochleocerebral (1)
- retrospective study (1)
- revision (1)
- rheumatoid (1)
- right inferior frontalgyrus (1)
- risk factor (1)
- risk-factors (1)
- roentgenographic assessment (1)
- rolipram (1)
- salvage radiotherapy (1)
- scaffolds (1)
- scale (1)
- sclerostin (1)
- screening for distress (1)
- search filter (1)
- secondary brain damage (1)
- secondary cancer (1)
- secondary lung tumors (1)
- self-diffusion (1)
- senescence (1)
- septal hypertrophy (1)
- septic (1)
- sequence imaging protocol (1)
- sequence variations (1)
- serogroup-Y (1)
- serotonin (1)
- serum (1)
- serum creatinine (1)
- severity (1)
- signature (1)
- single-nucleotide polymorphisms (1)
- small interfering RNAs (1)
- somatic mosaicism (1)
- spectrum disorders (1)
- spinal cord (1)
- spinal-cord (1)
- sporadic Parkinson's disease (1)
- stage renal-disease (1)
- staib agar (1)
- standardization (1)
- stem cells (1)
- steroids (1)
- streptozotocin (1)
- stroke register (1)
- stroke therapy (1)
- stroke unit (1)
- stroke unit care (1)
- structural determination (1)
- substance dependence (1)
- substance use disorder (1)
- substantia nigra (1)
- subthalamic nucleus (1)
- sudden cardiac death (1)
- suicide attempt (1)
- superficial peroneal nerve (1)
- sural nerve (1)
- surrogate endpoints (1)
- surveillance (1)
- survival analysis (1)
- survivin (1)
- sustained fear (1)
- symptoms (1)
- synovial fluid (1)
- synovitis (1)
- synthetic mesh (1)
- systolic dysfunction (1)
- tapered stem (1)
- targeted (1)
- task force (1)
- tenofovir disaproxil fumarate (1)
- term mortality (1)
- territory infaction (1)
- testicular neoplasms (1)
- therapeutic strategy (1)
- thymic carcinoma (1)
- thymoma (1)
- thymus (1)
- tinnitus (1)
- tissue engineering (1)
- transcranial direct current stimulation (1)
- transfection (1)
- transforming growth factor-beta 1 (1)
- translational stroke research (1)
- transplantation (1)
- transverse relaxation (1)
- treatment outcome (1)
- treatment response (1)
- treg cells (1)
- tremor (1)
- tuberculous meningitis (1)
- tumor (1)
- tumor stem cells (1)
- tumor-draining lymph node (1)
- tumorigenesis (1)
- twin study (1)
- type-1 matrix (1)
- uPA (1)
- ubiquitin (1)
- umbilical hernia (1)
- univentricular heart (1)
- urinary bladder neoplasms (1)
- urinary protein excretion (1)
- urine (1)
- vaccination (1)
- vaccines (1)
- vaccinia virus (1)
- vacuum conditioning (1)
- variants (1)
- varicella (1)
- vascular calcification (1)
- vascular type (1)
- vasculitis (1)
- vasculopathy (1)
- velocity (1)
- ventral hernia (1)
- ventricular tachycardia (1)
- vertebral fractures (1)
- viral replication (1)
- virions (1)
- virulence (1)
- visual (1)
- vitamin D (1)
- volume determination (1)
- whole body MRI (1)
- whole-body (1)
- whole-brain radiotherapy (1)
- α-galactosidase A (1)
- α-synuclein (1)
- β1 integrin (1)
Institute
- Medizinische Klinik und Poliklinik I (29)
- Neurologische Klinik und Poliklinik (26)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (19)
- Institut für Klinische Epidemiologie und Biometrie (10)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (10)
- Medizinische Klinik und Poliklinik II (10)
- Pathologisches Institut (10)
- Theodor-Boveri-Institut für Biowissenschaften (9)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (8)
- Klinik und Poliklinik für Nuklearmedizin (8)
- Physikalisches Institut (8)
- Institut für Molekulare Infektionsbiologie (7)
- Institut für Humangenetik (6)
- Lehrstuhl für Orthopädie (6)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (5)
- Neurochirurgische Klinik und Poliklinik (5)
- Institut für Virologie und Immunbiologie (4)
- Kinderklinik und Poliklinik (4)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (4)
- Rudolf-Virchow-Zentrum (4)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (3)
- Frauenklinik und Poliklinik (3)
- Institut für Anatomie und Zellbiologie (3)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (3)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (3)
- Urologische Klinik und Poliklinik (3)
- Institut für Hygiene und Mikrobiologie (2)
- Institut für Informatik (2)
- Institut für Pharmakologie und Toxikologie (2)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Institut für Psychologie (2)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (2)
- Klinik und Poliklinik für Strahlentherapie (2)
- Lehrstuhl für Biochemie (2)
- Medizinische Fakultät (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Augenklinik und Poliklinik (1)
- Institut für Klinische Biochemie und Pathobiochemie (1)
- Institut für Klinische Neurobiologie (1)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (1)
- Institut für Mathematik (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
- Julius-von-Sachs-Institut für Biowissenschaften (1)
- Klinik für Anaesthesiologie (bis 2003) (1)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (1)
- Lehrstuhl für Molekulare Psychiatrie (1)
- Missionsärztliche Klinik (1)
Sonstige beteiligte Institutionen
Background
Adrenal incidentalomas with cortisol autonomy are associated with increased cardiovascular morbidity and mortality. Specific data on the clinical and biochemical course of affected patients are lacking.
Methods
Retrospective study from a tertiary referral centre in Germany. After exclusion of overt hormone excess, malignancy and glucocorticoid medication, patients with adrenal incidentalomas were stratified according to serum cortisol after 1 mg dexamethasone: autonomous cortisol secretion (ACS), >5.0; possible ACS (PACS), 1.9-5.0; non-functioning adenomas (NFA), ≤1.8 µg/dl.
Results
A total of 260 patients were enrolled (147 women (56.5%), median follow-up 8.8 (2.0-20.8) years). At initial diagnosis, median age was 59.5 (20-82) years, and median tumour size was 27 (10-116) mm. Bilateral tumours were more prevalent in ACS (30.0%) and PACS (21.9%) than in NFA (8.1%). Over time, 40/124 (32.3%) patients had a shift of their hormonal secretion pattern (NFA to PACS/ACS, n=15/53; PACS to ACS, n=6/47; ACS to PACS, n=11/24; PACS to NFA, n=8/47). However, none of the patients developed overt Cushing’s syndrome. Sixty-one patients underwent adrenalectomy (NFA, 17.9%; PACS, 24.0%; ACS, 39.0%). When non-operated patients with NFA were compared to PACS and ACS at last follow-up, arterial hypertension (65.3% vs. 81.9% and 92.0%; p<0.05), diabetes (23.8% vs. 35.6% and 40.0%; p<0.01), and thromboembolic events (PACS: HR 3.43, 95%-CI 0.89-13.29; ACS: HR 5.96, 95%-CI 1.33-26.63; p<0.05) were significantly less frequent, along with a trend towards a higher rate of cardiovascular events in case of cortisol autonomy (PACS: HR 2.23, 95%-CI 0.94-5.32; ACS: HR 2.60, 95%-CI 0.87-7.79; p=0.1). Twenty-five (12.6%) of the non-operated patients died, with higher overall mortality in PACS (HR 2.6, 95%-CI 1.0-4.7; p=0.083) and ACS (HR 4.7, 95%-CI 1.6-13.3; p<0.005) compared to NFA. In operated patients, prevalence of arterial hypertension decreased significantly (77.0% at diagnosis to 61.7% at last follow-up; p<0.05). The prevalence of cardiovascular events and mortality did not differ significantly between operated and non-operated patients, whereas thromboembolic events were significantly less frequent in the surgical treatment group.
Conclusion
Our study confirms relevant cardiovascular morbidity in patients with adrenal incidentalomas (especially those with cortisol autonomy). These patients should therefore be monitored carefully, including adequate treatment of typical cardiovascular risk factors. Adrenalectomy was associated with a significantly decreased prevalence of hypertension. However, more than 30% of patients required reclassification according to repeated dexamethasone suppression tests. Thus, cortisol autonomy should ideally be confirmed before making any relevant treatment decision (e.g. adrenalectomy).
Combined MEK‐BRAF inhibition is a well‐established treatment strategy in BRAF‐mutated cancer, most prominently in malignant melanoma with durable responses being achieved through this targeted therapy. However, a subset of patients face primary unresponsiveness despite presence of the activating mutation at position V600E, and others acquire resistance under treatment. Underlying resistance mechanisms are largely unknown, and diagnostic tests to predict tumor response to BRAF‐MEK inhibitor treatment are unavailable.
Multiple myeloma represents the second most common hematologic malignancy, and point mutations in BRAF are detectable in about 10% of patients. Targeted inhibition has been successfully applied, with mixed responses observed in a substantial subset of patients mirroring the widespread spatial heterogeneity in this genomically complex disease. Central nervous system (CNS) involvement is an extremely rare, extramedullary form of multiple myeloma that can be diagnosed in less than 1% of patients. It is considered an ultimate high‐risk feature, associated with unfavorable cytogenetics, and, even with intense treatment applied, survival is short, reaching less than 12 months in most cases. Here we not only describe the first patient with an extramedullary CNS relapse responding to targeted dabrafenib and trametinib treatment, we furthermore provide evidence that a point mutation within the capicua transcriptional repressor (CIC) gene mediated the acquired resistance in this patient.
The mechanisms of mechanical energy recovery during gait have been thoroughly investigated in healthy subjects, but never described in patients with Parkinson disease (PD). The aim of this study was to investigate whether such mechanisms are preserved in PD patients despite an altered pattern of locomotion. We consecutively enrolled 23 PD patients (mean age 64±9 years) with bilateral symptoms (H&Y ≥II) if able to walk unassisted in medication-off condition (overnight suspension of all dopaminergic drugs). Ten healthy subjects (mean age 62±3 years) walked both at their ‘preferred’ and ‘slow’ speeds, to match the whole range of PD velocities. Kinematic data were recorded by means of an optoelectronic motion analyzer. For each stride we computed spatio-temporal parameters, time-course and range of motion (ROM) of hip, knee and ankle joint angles. We also measured kinetic (Wk), potential (W\(_{p}\)), total (W\(_{totCM}\)) energy variations and the energy recovery index (ER). Along with PD progression, we found a significant correlation of W\(_{totCM}\) and W\(_{p}\) with knee ROM and in particular with knee extension in terminal stance phase. W\(_{k}\) and ER were instead mainly related to gait velocity. In PD subjects, the reduction of knee ROM significantly diminished both W\(_{p}\) and W\(_{totCM}\). Rehabilitation treatments should possibly integrate passive and active mobilization of knee to prevent a reduction of gait-related energetic components.
Background
There is a need to establish more cell lines from breast tumors in contrast to immortalized cell lines from metastatic effusions in order to represent the primary tumor and not principally metastatic biology of breast cancer. This investigation describes the simultaneous isolation, characterization, growth and function of primary mammary epithelial cells (MEC), mesenchymal cells (MES) and adipose derived stem cells (ADSC) from four normal breasts, one inflammatory and one triple-negative ductal breast tumors.
Methods
A total of 17 cell lines were established and gene expression was analyzed for MEC and MES (n = 42) and ADSC (n = 48) and MUC1, pan-KRT, CD90 and GATA-3 by immunofluorescence. DNA fingerprinting to track cell line identity was performed between original primary tissues and isolates. Functional studies included ADSC differentiation, tumor MES and MEC invasion co-cultured with ADSC-conditioned media (CM) and MES adhesion and growth on 3D-printed scaffolds.
Results
Comparative analysis showed higher gene expression of EPCAM, CD49f, CDH1 and KRTs for normal MEC lines; MES lines e.g. Vimentin, CD10, ACTA2 and MMP9; and ADSC lines e.g. CD105, CD90, CDH2 and CDH11. Compared to the mean of all four normal breast cell lines, both breast tumor cell lines demonstrated significantly lower ADSC marker gene expression, but higher expression of mesenchymal and invasion gene markers like SNAI1 and MMP2. When compared with four normal ADSC differentiated lineages, both tumor ADSC showed impaired osteogenic and chondrogenic but enhanced adipogenic differentiation and endothelial-like structures, possibly due to high PDGFRB and CD34. Addressing a functional role for overproduction of adipocytes, we initiated 3D-invasion studies including different cell types from the same patient. CM from ADSC differentiating into adipocytes induced tumor MEC 3D-invasion via EMT and amoeboid phenotypes. Normal MES breast cells adhered and proliferated on 3D-printed scaffolds containing 20 fibers, but not on 2.5D-printed scaffolds with single fiber layers, important for tissue engineering.
Conclusion
Expression analyses confirmed successful simultaneous cell isolations of three different phenotypes from normal and tumor primary breast tissues. Our cell culture studies support that breast-tumor environment differentially regulates tumor ADSC plasticity as well as cell invasion and demonstrates applications for regenerative medicine.
Current guidelines recommend consolidation with autologous stem cell transplantation (autoSCT) after induction chemotherapy for most patients with peripheral T-cell lymphoma (PTCL). This assumption is based on five prospective phase II studies, three of which included <50 patients with limited follow-up. Here we present the final analysis of the prospective German study. The treatment regimen consisted of four to six cycles of CHOP chemotherapy followed by mobilizing therapy and stem cell collection. Patients in complete remission (CR) or partial remission (PR) underwent myeloablative chemo(radio)therapy and autoSCT. From January 2001 to July 2010, 111 patients were enrolled in the study. The main subgroups were PTCL not specified (n=42) and angioimmunoblastic T-cell lymphoma (n=37). Seventy-five (68%) of the 111 patients received transplantation. The main reason for not receiving autoSCT was progressive disease. In an intent-to-treat analysis, the complete response rate after myeloablative therapy was 59%. The estimated 5-year overall survival, disease-free survival and progression-free survival rates were 44%, 54% and 39%, respectively. The results of this study confirm that upfront autoSCT can result in long-term remissions in patients with all major subtypes of PTCL and therefore should be part of first-line therapy whenever possible.
Fractal phenomena can be found in numerous scientific areas including neuroscience. Fractals are structures, in which the whole has the same shape as its parts. A specific structure known as pink noise (also called fractal or 1/f noise) is one key fractal manifestation, exhibits both stability and adaptability, and can be addressed via the Hurst exponent (H). FMRI studies using H on regional fMRI time courses used fractality as an important characteristic to unravel neural networks from artificial noise. In this fMRI-study, we examined 103 healthy male students at rest and while performing the 5-choice serial reaction time task. We addressed fractality in a network associated with waiting impulsivity using the adaptive fractal analysis (AFA) approach to determine H. We revealed the fractal nature of the impulsivity network. Furthermore, fractality was influenced by individual impulsivity in terms of decreasing fractality with higher impulsivity in regions of top-down control (left middle frontal gyrus) as well as reward processing (nucleus accumbens and anterior cingulate cortex). We conclude that fractality as determined via H is a promising marker to quantify deviations in network functions at an early stage and, thus, to be able to inform preventive interventions before the manifestation of a disorder.
Interleukin-2-regulatory T cell axis critically regulates maintenance of hematopoietic stem cells
(2017)
The role of IL-2 in HSC maintenance is unknown. Here we show that Il2\(^{−/-}\) mice develop severe anomalies in HSC maintenance leading to defective hematopoiesis. Whereas, lack of IL-2 signaling was detrimental for lympho- and erythropoiesis, myelopoiesis was enhanced in Il2\(^{−/-}\) mice. Investigation of the underlying mechanisms of dysregulated hematopoiesis in Il2\(^{−/-}\) mice shows that the IL-2-T\(_{reg}\) cell axis is indispensable for HSC maintenance and normal hematopoiesis. Lack of T\(_{reg}\) activity resulted in increased IFN-γ production by activated T cells and an expansion of the HSCs in the bone marrow (BM). Though, restoring T\(_{reg}\) population successfully rescued HSC maintenance in Il2\(^{-/-}\) mice, preventing IFN-γ activity could do the same even in the absence of T\(_{reg}\) cells. Our study suggests that equilibrium in IL-2 and IFN-γ activity is critical for steady state hematopoiesis, and in clinical conditions of BM failure, IL-2 or anti-IFN-γ treatment might help to restore hematopoiesis.
Tinnitus is the perception of a phantom sound that affects between 10 and 15% of the general population. Despite this considerable prevalence, treatments for tinnitus are presently lacking. Tinnitus exhibits a diverse array of recognized risk factors and extreme clinical heterogeneity. Furthermore, it can involve an unknown number of auditory and non-auditory networks and molecular pathways. This complex combination has hampered advancements in the field. The identification of specific genetic factors has been at the forefront of several research investigations in the past decade. Nine studies have examined genes in a case-control association approach. Recently, a genome-wide association study has highlighted several potentially significant pathways that are implicated in tinnitus. Two twin studies have calculated a moderate heritability for tinnitus and disclosed a greater concordance rate in monozygotic twins compared to dizygotic twins. Despite the more recent data alluding to genetic factors in tinnitus, a strong association with any specific genetic locus is lacking and a genetic study with sufficient statistical power has yet to be designed. Future research endeavors must overcome the many inherent limitations in previous study designs. This review summarizes the previously embarked upon tinnitus genetic investigations and summarizes the hurdles that have been encountered. The identification of candidate genes responsible for tinnitus may afford gene based diagnostic approaches, effective therapy development, and personalized therapeutic intervention.
In the last decades significant regulatory attempts were made to replace, refine and reduce animal testing to assess the risk of consumer products for the human eye. As the original in vivo Draize eye test is criticized for limited predictivity, costs and ethical issues, several animal-free test methods have been developed to categorize substances according to the global harmonized system (GHS) for eye irritation. This review summarizes the progress of alternative test methods for the assessment of eye irritation. Based on the corneal anatomy and current knowledge of the mechanisms causing eye irritation, different ex vivo and in vitro methods will be presented and discussed with regard to possible limitations and status of regulatory acceptance. In addition to established in vitro models, this review will also highlight emerging, full thickness cornea models that might be suited to predict all GHS categories.
Background:
Early-onset obsessive-compulsive disorder (OCD) is one of the more common mental illnesses of children and adolescents, with prevalence of 1% to 3%. Its manifestations often lead to severe impairment and to conflict in the family. In this review, we summarize the manifestations, comorbidity, pathophysiology, and course of this disease as well as current modes of diagnosis and treatment.
Methods:
We selectively review the relevant literature and the German-language guidelines for the diagnosis and treatment of mental illnesses in children and adolescents.
Results:
Obsessive-compulsive manifestations are of many types and cause severe impairment. Comorbid mental disturbances are present in as many as 70% of patients. The disease takes a chronic course in more than 40% of patients. Cognitive behavioral therapy is the treatment of first choice, followed by combination pharmacotherapy including selective serotonin reuptake inhibitors (SSRI) and then by SSRI alone.
Conclusion:
OCD often begins in childhood or adolescence. There are empirically based neurobiological and cognitive-behavioral models of its pathophysiology. Multiaxial diagnostic evaluation permits early diagnosis. Behavioral therapy and medications are highly effective treatments, but the disorder nonetheless takes a chronic course in a large percentage of patients.